Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
8.20
-0.62 (-7.03%)
At close: May 14, 2026, 4:00 PM EDT
8.00
-0.20 (-2.44%)
After-hours: May 14, 2026, 4:53 PM EDT
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $300.9 million as of May 14, 2026. Its market cap has increased by 422.87% in one year.
Market Cap
300.90M
Enterprise Value
683.03M
1-Year Change
422.87%
Ranking
Category
Stock Price
$8.20
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $300.90M, an increase of 549.69%. That is a compound annual growth rate of 30.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2026 | 300.90M | 31.61% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 337.31M |
| Bicycle Therapeutics | 330.41M |
| Silence Therapeutics | 329.70M |
| Neumora Therapeutics | 325.18M |
| Abeona Therapeutics | 324.80M |
| Inhibikase Therapeutics | 323.80M |
| Nuvectis Pharma | 319.37M |
| Lineage Cell Therapeutics | 319.10M |